1
|
Tixier MS, Douin M, Kreiter S. Phytoseiidae (Acari: Mesostigmata) on plants of the family Solanaceae: results of a survey in the south of France and a review of world biodiversity. Exp Appl Acarol 2020; 81:357-388. [PMID: 32524213 DOI: 10.1007/s10493-020-00507-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Accepted: 05/28/2020] [Indexed: 06/11/2023]
Abstract
Species of the family Phytoseiidae are predators of pest mites and small insects. Their biodiversity is not equally known according to regions and supporting plants. This paper focuses on Phytoseiidae species on plants of the family Solanaceae. The Solanaceae contain many cultivated plants, for example tomato on which leaf characteristics hinder Phytoseiidae settlement and dispersal. This study presents (i) results of surveys carried out on Solanaceae in the south of France, and (ii) Phytoseiidae biodiversity on Solanaceae worldwide. Eleven species were retrieved on 20 solanaceous plants in the south of France with four main species: Euseius gallicus, Euseius stipulatus, Phytoseiulus persimilis and Typhlodromus (Anthoseius) recki. The global analysis suggests that much more species might be found enhancing sampling efforts, whatever the biogeographic region considered. Five Phytoseiidae genera concentrate the highest number of reports and species [Amblyseius, Neoseiulus, Euseius, Phytoseius and Typhlodromus (Anthoseius)]. These genera are not evolutionarily related; adaptation on Solanaceae seems to be recent, except in the Neotropical region. The latter region represents the highest number of reports, species and Solanaceae plants sampled, probably as the centre of origin of this plant family. Occurrence probabilities in biogeographic regions and plant genera are provided as a baseline for searching for new predators adapted to Solanaceae.
Collapse
Affiliation(s)
- M-S Tixier
- CBGP, Montpellier SupAgro, INRA, CIRAD, IRD, University of Montpellier, Campus International de Baillarguet, CS 30016, 34988, Montpellier, Montferrier-sur-Lez cedex, France.
| | - M Douin
- CBGP, Montpellier SupAgro, INRA, CIRAD, IRD, University of Montpellier, Campus International de Baillarguet, CS 30016, 34988, Montpellier, Montferrier-sur-Lez cedex, France
| | - S Kreiter
- CBGP, Montpellier SupAgro, INRA, CIRAD, IRD, University of Montpellier, Campus International de Baillarguet, CS 30016, 34988, Montpellier, Montferrier-sur-Lez cedex, France
| |
Collapse
|
2
|
Armengol J, Weigand S, Von Tiedemann A, Kreiter S, Duso C. Education in crop protection: Erasmus Mundus Joint Master Degree – European Master Degree in Plant Health in Sustainable Cropping Systems. J Biotechnol 2019. [DOI: 10.1016/j.jbiotec.2019.05.044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
3
|
Schmidt M, Bolte S, Frenzel K, Heesen L, Derhovanessian E, Bukur V, Diken M, Gruetzner J, Kreiter S, Klein A, Kuhn A, Langer D, Loewer M, Lindman H, Schneeweiss A, Tuereci O, Sahin U. Abstract OT2-06-01: Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-ot2-06-01] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The treatment of triple negative breast cancer (TNBC) is hampered by the lack of established therapeutic targets such as hormone receptors or HER-2. Chemotherapy and radiotherapy is the standard of care, yet survival rates in TNBC remain poor. Approaches tailored to the patient's individual tumor signature may lead to improved therapeutic outcome. We have set up a clinical workflow covering drug development (from target discovery to manufacturing) and drug release providing a custom-made investigational medicinal product (IMP) for each individual patient.
Trial Design: A phase I/II trial assesses the feasibility, safety and biological efficacy of this personalized immunotherapy in three clinical sites in Germany and Sweden. TNBC patients (pT1cN0M0 – TxNxM0) after completion of initial standard of care therapy will be allocated to one of two study arms. Patients in ARM1 receive 8 vaccination cycles with a personalized combination of shared tumor-associated antigens, selected based on each patient tumor's antigen-expression profile out of a WAREHOUSE of pre-manufactured mRNA vaccine. Patients in ARM2 receive the personalized mRNA WAREHOUSE vaccine followed by 8 vaccination cycles of an on-demand manufactured mRNA MUTANOME vaccine encoding up to twenty unique neo-epitopes of the individual patient identified by next generation sequencing. The mRNAs are administered intravenously as a nanoparticulate lipoplex formulation, which protects RNA from degradation, activates innate immunity, transfects APCs and consequently induces highly potent antigen-specific T-cell responses. The treatment of 12 patients in ARM1 is completed and enrolment of patients for ARM2 has started. Preliminary data show that the RNA-WAREHOUSE approach is feasible and can be applied safely. Biomarker analysis is ongoing. This approach is promising as it addresses the heterogeneity of TNBC.
The TNBC-MERIT trial was initially funded by the EU Commission's FP7 and led by BioNTech AG.
Citation Format: Schmidt M, Bolte S, Frenzel K, Heesen L, Derhovanessian E, Bukur V, Diken M, Gruetzner J, Kreiter S, Klein A, Kuhn A, Langer D, Loewer M, Lindman H, Schneeweiss A, Tuereci O, Sahin U. Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr OT2-06-01.
Collapse
Affiliation(s)
- M Schmidt
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - S Bolte
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - K Frenzel
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - L Heesen
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - E Derhovanessian
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - V Bukur
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - M Diken
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - J Gruetzner
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - S Kreiter
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - A Klein
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - A Kuhn
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - D Langer
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - M Loewer
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - H Lindman
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - A Schneeweiss
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - O Tuereci
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| | - U Sahin
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany; TRON gGmbH, Mainz, Germany; Uppsala University Hospital, Uppsala, Sweden; Sektion Gynäkologische Onkologie, NCT Heidelberg, Heidelberg, Germany
| |
Collapse
|
4
|
Jabulowsky R, Loquai C, Derhovanessian E, Mitzel-Rink H, Utikal J, Hassel J, Kaufmann R, Pinter A, Diken M, Gold M, Heesen L, Schreeb K, Schwarck-Kokarakis D, Kreiter S, Gaiser M, Jäger D, Grabbe S, Türeci Ö, Sahin U. A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy288.109] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
5
|
Heesen L, Frenzel K, Bolte S, Bukur V, Diken M, Derhovanessian E, Kreiter S, Kuhn A, Kühlcke K, Löwer M, Lindman H, Pascolo S, Schmidt M, Schneeweiss A, Sjöblom T, Thielemans K, Zitvogel L, Türeci Ö, Sahin U. Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy270.264] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
6
|
Frenzel K, Heesen L, Bolte S, Bukur V, Diken M, Derhovanessian E, Kreiter S, Kuhn A, Kuehlcke K, Löwer M, De Greve J, Lindman H, Pascolo S, Schmidt M, Schneeweiss A, Sjöblom T, Thielemans K, Zitvogel L, Türeci Ö, Sahin U. Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx711.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Kloke BP, Kreiter S, Vormehr M, Diken M, Kuhn AN, Sahin U. Actively personalized cancer vaccines--the step into clinical application. Pharmazie 2016; 71:43-47. [PMID: 26867352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Cancer vaccine development enters a new phase of innovation based on the development of modern sequencing technologies and novel RNA-based synthetic drug formats which enable the analysis and therapeutic targeting of every patient's tumor genome. By applying and combining these innovations, we have brought the concept of "actively personalized cancer vaccines" to clinical testing. Synthetic RNA is used as the drug format, allowing affordable, individual "on demand" manufacturing of tumor-optimized vaccines.
Collapse
|
8
|
Boisguérin V, Castle JC, Loewer M, Diekmann J, Mueller F, Britten CM, Kreiter S, Türeci Ö, Sahin U. Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside. Br J Cancer 2014; 111:1469-75. [PMID: 25314223 PMCID: PMC4200076 DOI: 10.1038/bjc.2013.820] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2013] [Revised: 11/22/2013] [Accepted: 12/09/2013] [Indexed: 12/25/2022] Open
Abstract
Cancer is a disease caused by DNA mutations. Cancer therapies targeting defined functional mutations have shown clinical benefit. However, as 95% of the mutations in a tumour are unique to that single patient and only a small number of mutations are shared between patients, the addressed medical need is modest. A rapidly determined patient-specific tumour mutation pattern combined with a flexible mutation-targeting drug platform could generate a mutation-targeting individualised therapy, which would benefit each single patient. Next-generation sequencing enables the rapid identification of somatic mutations in individual tumours (the mutanome). Immunoinformatics enables predictions of mutation immunogenicity. Mutation-targeting RNA-based vaccines can be rapidly and affordably synthesised as custom GMP drug products. Integration of these cutting-edge technologies into a clinically applicable process holds the promise of a disruptive innovation benefiting cancer patients. Here, we describe our translation of the individualised RNA-based cancer vaccine concept into clinic trials.
Collapse
Affiliation(s)
- V Boisguérin
- 1] TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany [2] BioNTech AG, Hölderlinstr 8, 55131 Mainz, Germany
| | - J C Castle
- TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany
| | - M Loewer
- TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany
| | - J Diekmann
- TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany
| | - F Mueller
- 1] TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany [2] BioNTech AG, Hölderlinstr 8, 55131 Mainz, Germany [3] TheraCode GmbH, Hölderlinstr 8, 55131 Mainz, Germany
| | - C M Britten
- 1] TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany [2] Ribological GmbH, Hölderlinstr 8, 55130 Mainz, Germany
| | - S Kreiter
- TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany
| | - Ö Türeci
- 1] University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany [2] Ganymed Pharmaceuticals AG, Freiligrathstraße 12, 55131 Mainz, Germany
| | - U Sahin
- 1] TRON gGmbH-Translational Oncology at Johannes Gutenberg-University Medical Center gGmbH, Langenbeckstr 1, Building 708, 55131 Mainz, Germany [2] BioNTech AG, Hölderlinstr 8, 55131 Mainz, Germany [3] University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| |
Collapse
|
9
|
Ferrero M, Tixier MS, Kreiter S. Different feeding behaviours in a single predatory mite species. 2. Responses of two populations of Phytoseiulus longipes (Acari: Phytoseiidae) to various prey species, prey stages and plant substrates. Exp Appl Acarol 2014; 62:325-335. [PMID: 24114341 DOI: 10.1007/s10493-013-9746-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Accepted: 09/26/2013] [Indexed: 06/02/2023]
Abstract
Tritrophic studies involving several populations of the predatory mite Phytoseiulus longipes showed distinct life history traits depending on the prey offered and/or the plant substrate. In order to better understand the biology of this predator, the response to several combinations of prey species (Tetranychus evansi and Tetranychus urticae), prey stages (eggs and mobile stages) and plant substrates (bean and tomato leaf discs) has been assessed for two populations of P. longipes. Unlike what was found for life history traits, both populations displayed similar behaviour: they went and stayed more on tomato than on bean, they preferred T. urticae over T. evansi and mobile stages over eggs. Combining the previous life history data with the present results suggests that P. longipes may display host-plant mediated specialization on a prey species, T. evansi. Possible underlying mechanisms are discussed, as well as directions for future work.
Collapse
Affiliation(s)
- M Ferrero
- Unité Mixte de Recherche Centre de Biologie pour la Gestion des Populations CIRAD/INRA/IRD/Montpellier SupAgro, Montpellier SupAgro, Campus International de Baillarguet, CS 30 016, 34988, Montferrier-sur-Lez Cedex, France,
| | | | | |
Collapse
|
10
|
Ferrero M, Tixier MS, Kreiter S. Different feeding behaviors in a single predatory mite species. 1. Comparative life histories of three populations of Phytoseiulus longipes (Acari: Phytoseiidae) depending on prey species and plant substrate. Exp Appl Acarol 2014; 62:313-24. [PMID: 24114340 DOI: 10.1007/s10493-013-9745-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Accepted: 09/26/2013] [Indexed: 05/09/2023]
Abstract
The spider mites Tetranychus evansi and T. urticae are key pests of tomato crops, for which no sustainable practical control strategy is available yet. A Brazilian (B) and an Argentinean (A) population of a phytoseiid predatory mite species, Phytoseiulus longipes, are able to develop and reproduce on T. evansi on tomato, whereas a Chilean (C) population is not. In order to better characterize the two distinct feeding behaviours of these three populations, life table data were assessed when the predator was offered T. evansi or T. urticae as prey on bean or tomato leaves. No effect of the prey offered nor the plant substrate was demonstrated on development durations of the three populations. However, immature mortality was low for the Argentinean and the Brazilian populations whatever the prey or plant substrate, whereas 89 % of P. longipes from Chile died before reaching adulthood when fed T. evansi on tomato. No difference in effect on female longevity was detected among the three populations. Finally, the demographic parameters of all populations were lower in presence of tomato compared to beans. Possible explanations for these results are discussed.
Collapse
Affiliation(s)
- M Ferrero
- Montpellier SupAgro, Unité Mixte de Recherche Centre de Biologie Pour la Gestion des Populations CIRAD/INRA/IRD/Montpellier SupAgro, Campus International de Baillarguet, CS 30 016, 34 988, Montferrier-sur-Lez Cedex, France,
| | | | | |
Collapse
|
11
|
Azimi A, Kuznecovs S, Kuznecovs J, Blazejczyk A, Switalska M, Chlopicki S, Marcinek A, Gebicki J, Wietrzyk J, Egyhazi S, Azimi A, Ghasghgaei S, Frostvik Stolt M, Hertzman Johansson C, Hansson J, Delage JD, Li H, Lu H, Cazin LH, Vannier JP, Drouet L, Dupuy E, Soria J, Varin R, Soria C, Castle J, Kreiter S, Diekmann J, Lower M, van der Roemer N, de Graaf J, Selmi S, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Tureci O, Sahin U, Procopio G, Verzoni E, Testa I, de Braud F, Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravergna G, Bencardino K, Cercek A, Chen C, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, di Nicolantonio F, Solit D, Bardelli A, Burbridge MF, Dovat SP, Song C, Payne KJ, Yang L, Cree A, Glaysher M, Bolton L, Johnson P, Atkey N, Torrance C, Bogush TA, Dudko EA, Shaturova AS, Tikhomirov MV, Bogush EA, Polotsky BE, Tjulandin SA, Davydov MI, Hertzman Johansson C, Azimi A, Pernemalm M, Pawitan Y, Frostvik Stolt M, Lazar V, Lundeberg J, Lehtio J, Egyhazi S, Hansson J, Rasul A, Ma T, Dyshlovoy SA, Naeth I, Venz S, Fedorov SN, Shubina LK, Stonik VA, Balabanov S, Honecker F, Kongpracha P, Tohtong R, Demidkina V, Kudryavtsev VA, Kabakov AE, Golan T, Atias D, Barshack I, Avivi C, Goldstein RS, Berger R, Ben-Arieh S, Urban D, Maimon N, Leibowitz-Amit R, Keizman D, Biran H, Mishaeli M, Onn A, Gottfried M, Saraswati S, Agrawal SS, Raval P, Patel M, Ganure L, Hanen JH, Sonia BHK, Aya M, Zohra H, Touhami M, Cheng X, Shi TY, Yang L, Yang G, Tu XY, Wu XH, Wei QY, Benboubker H, Zheng BQ, Shi YQ, He XH, Liang LH, Saied GM. Therapeutics. Ann Oncol 2012. [DOI: 10.1093/annonc/mds162] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Okassa M, Kreiter S, Tixier MS. Obtaining molecular data for all life stages of Typhlodromus (Typhlodromus) exhilaratus (Mesostigmata: Phytoseiidae): consequences for species identification. Exp Appl Acarol 2012; 57:105-116. [PMID: 22456812 DOI: 10.1007/s10493-012-9548-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2011] [Accepted: 03/12/2012] [Indexed: 05/31/2023]
Abstract
Several species of the family Phytoseiidae are known to control mite pests in many crops worldwide. However, biological control success greatly depends on the accurate identification of these predatory mites. Species diagnostics is essentially based on the morphological characters of females. Thus, when only immature stages and/or males are collected, their identification is poorly supported. Molecular tools could be of great help to overcome these difficulties, as molecular sequences are assumed to be identical for the life stage considered. However, one of the essential points is to extract a sufficient DNA amount from a single specimen of immature stages (eggs, protonymphs, deutonymphs) and males (less than 300 μm in length) to amplify and sequence DNA. The markers used were two mitochondrial DNA fragments (12S rRNA and Cytb mtDNA) and the species studied were Typhlodromus (Typhlodromus) exhilaratus and T. (T.) phialatus, two cryptic species, reported to control mite pests in crops of southern Europe and commonly found on the same plants. Despite a low quantity of DNA extracted, particularly for the egg, larva and protonymph stages, DNA was amplified and sequences were obtained from all the life stages considered with the two mtDNA fragments. Sequences from all the developmental stages of T. (T.) exhilaratus were identical and well differentiated from those of its sister-species. However, contaminations were observed especially for eggs and DNA amplified with the Cytb mt marker. Utility of the present results are discussed and protocol improvements are proposed.
Collapse
Affiliation(s)
- M Okassa
- Montpellier SupAgro, Unité Mixte de Recherche no1062 Centre de Biologie et de Gestion des Populations, Campus International de Baillarguet, CS 30016, 34988, Montferrier sur Lez cedex, France
| | | | | |
Collapse
|
13
|
Tixier MS, Ferrero M, Okassa M, Guichou S, Kreiter S. On the specific identity of specimens of Phytoseiulus longipes Evans (Mesostigmata: Phytoseiidae) showing different feeding behaviours: morphological and molecular analyses. Bull Entomol Res 2010; 100:569-579. [PMID: 20158926 DOI: 10.1017/s0007485309990617] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
This paper focuses on the differentiation of specimens, identified as Phytoseiulus longipes, collected in four countries: Argentina, Brazil, Chile and South Africa. Two of these populations are known to feed and develop on Tetranychus evansi, whereas the two others do not. As morphologically similar specimens can sometimes belong to different species and because differences in predatory behaviours exist among the four populations considered, we tested for the presence of cryptic species. Morphological and molecular experiments (12S rDNA) were carried out. The four studied populations of P. longipes could be morphologically differentiated thanks to a combination of characters. However, these morphological differences are very small. The two populations that feed and develop on T. evansi (from Argentina and Brazil) are morphologically closer to each other than to the two other populations. Genetic distances among the four populations of P. longipes were very low, suggesting that despite their different feeding habits, all specimens belong to the same species. However, the populations associated with T. evansi showed some genetic differentiation from those that do not use this pest. This is the first time that this type of differentiation has been reported for the family Phytoseiidae. These results are of primary importance to ensure the success of biological control programs and to develop strains adapted to both crops and prey species.
Collapse
Affiliation(s)
- M-S Tixier
- Montpellier SupAgro, Unité Mixte de Recherche no. 1062 Centre de Biologie et de Gestion des Populations, bâtiment 16, 2 Place Pierre Viala, 34060 Montpellier cedex 01, France.
| | | | | | | | | |
Collapse
|
14
|
Kuhn AN, Diken M, Kreiter S, Selmi A, Kowalska J, Jemielity J, Darzynkiewicz E, Huber C, Türeci O, Sahin U. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther 2010; 17:961-71. [PMID: 20410931 DOI: 10.1038/gt.2010.52] [Citation(s) in RCA: 156] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Vaccination with in vitro transcribed RNA coding for tumor antigens is considered a promising approach for cancer immunotherapy and has already entered human clinical testing. One of the basic objectives for development of RNA as a drug is the optimization of immunobioavailability of the encoded antigen in vivo. By analyzing the effect of different synthetic 5' mRNA cap analogs on the kinetics of the encoded protein, we found that m(2)(7,2'-O)Gpp(S)pG (beta-S-ARCA) phosphorothioate caps, in particular the D1 diastereoisomer, profoundly enhance RNA stability and translational efficiency in immature but not mature dendritic cells. Moreover, in vivo delivery of the antigen as beta-S-ARCA(D1)-capped RNA species is superior for protein expression and for efficient priming and expansion of naïve antigen-specific T cells in mice. Our findings establish 5' mRNA cap analogs as yet another module for tuning immunopharmacological properties of recombinant antigen-encoding RNA for vaccination purposes.
Collapse
Affiliation(s)
- A N Kuhn
- Division of Translational and Experimental Oncology, Department of Internal Medicine III, Johannes Gutenberg-University, Mainz, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
|
16
|
Okassa M, Tixier MS, Cheval B, Kreiter S. Molecular and morphological evidence for a new species status within the genus Euseius (Acari: Phytoseiidae). CAN J ZOOL 2009. [DOI: 10.1139/z09-057] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The identity of specimens belonging to the genus Euseius Wainstein, 1962 found on several trees in France is investigated. These specimens are morphologically close to Euseius stipulatus (Athias-Henriot, 1960) except for the shape of the spermatheca and the dorsal shield reticulation. The aim of the present study was to determine if these specimens belong to this latter species and if the shape of the spermatheca could be considered a reliable diagnostic character. Thirty-four characters, including idiosomal seta lengths, were measured and molecular tests (12S rDNA, COI mtDNA) were carried out. Although small, significant differences between populations of Euseius sp. were observed. The morphometric differences between E. stipulatus and Euseius sp. were very small except for the seta z2 and for the length of the ventrianal shield, as well as the length and form of the spermatheca. Molecular analyses support that Euseius sp. and E. stipulatus are two different species. Euseius sp. has been described as a new species to science in another publication under the name Euseius gallicus . Reliability of some morphological characters for species diagnosis is discussed.
Collapse
Affiliation(s)
- M. Okassa
- Montpellier SupAgro, Unité Mixte de Recherche 1062 CBGP, bâtiment 16, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
| | - M.-S. Tixier
- Montpellier SupAgro, Unité Mixte de Recherche 1062 CBGP, bâtiment 16, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
| | - B. Cheval
- Montpellier SupAgro, Unité Mixte de Recherche 1062 CBGP, bâtiment 16, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
| | - S. Kreiter
- Montpellier SupAgro, Unité Mixte de Recherche 1062 CBGP, bâtiment 16, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
| |
Collapse
|
17
|
Craddock C, Bardy P, Kreiter S, Johnston R, Apperley J, Marks D, Huber C, Kolbe K, Goulding R, Lawler M, Goldman J, Hughes T, Derigs G. Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen. Br J Haematol 2008. [DOI: 10.1111/j.1365-2141.2000.02454.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Tixier MS, Kreiter S, Croft BA, Cheval B. Kampimodromus aberrans (Acari: Phytoseiidae) from the USA: morphological and molecular assessment of its density. Bull Entomol Res 2008; 98:125-34. [PMID: 18076781 DOI: 10.1017/s0007485307005457] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Morphological measurements and a mitochondrial molecular marker (COI) were used to identity specimens reported as Kampimodromus aberrans on hazelnut in the USA. Several species and populations of this genus were studied to assist with identification. Both data types showed that specimens from the USA differed from K. aberrans from other regions. USA specimens seem to belong to the same species as Kampimodromus specimens from France on hazelnut. These mites were morphologically similar to Kampimodromus coryli and K. corylosus, which according to the original descriptions, are distinguished by the presence or absence of a tooth on the movable digit of the chelicera, with K. coryli having one tooth and K. corylosus none. As chelicerae of Kampimodromus from hazelnut in the USA and France are toothless, they are assigned to the species K. corylosus. Studies showed that morphological characters traditionally used to identify Kampimodromus species, such as setal length, are of less value than other characters that are difficult to observe, such as the numbers of solenostomes and the presence of teeth on the movable digit of the chelicerae. Some synonyms are discussed.
Collapse
Affiliation(s)
- M-S Tixier
- Ecole Nationale Supérieure Agronomique/Institut National de la Recherche Agronomique, Unité d'Ecologie Animale et de Zoologie Agricole, Laboratoire d'Acarologie, Montpellier Cedex 01, France.
| | | | | | | |
Collapse
|
19
|
Tixier MS, Kreiter S, Ferragut F, Cheval B. The suspected synonymy of Kampimodromus hmiminai and Kampimodromus adrianae (Acari: Phytoseiidae): morphological and molecular investigations. CAN J ZOOL 2006. [DOI: 10.1139/z06-108] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Kampimodromus hmiminai McMurtry and Bounfour, 1989 and Kampimodromus adrianae Ferragut and Peña-Estévez, 2003 are two morphogically close species belonging to the family Phytoseiidae. They are the only two species within the genus Kampimodromus Nesbitt, 1951 that bear six solenostomes and a reduced ventrianal shield. Only some characters, such as the idiosomal seta lengths, idiosomal dorsal ornamentation, and setae ornamentation, distinguish them. Kampimodromus hmiminai has being reported from France and Morocco and K. adrianae from the Canary Islands. Our study tests the hypothesis of synonymy between these two species, using morphological measurements and molecular typing (mtDNA, cytochrome C oxidase I (COI)). The differences in idiosomal setae lengths between K. adrianae and K. hmiminai seem to be large enough to support their species status. However, genetic distances between these two species correspond to an intraspecific range of variation. According to the present data, K. adrianae and K. hmiminai could be considered synonyms, with morphologic differentiation as a result of geographic isolation. This result indicates that comparative setal length, seta serration, and dorsal shield ornementation should be used with caution for species differentiation within the genus Kampimodromus .
Collapse
Affiliation(s)
- M.-S. Tixier
- Ecole nationale supérieure agronomique / Institut national de la recherche agronomique (INRA), Unité d’écologie animale et de zoologie agricole, Laboratoire d’acarologie, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
- Instituto Agroforestal Mediterraneo, Universidad Politecnica de Valencia, camino de Vera, 14, 46022 Valencia, Spain
| | - S. Kreiter
- Ecole nationale supérieure agronomique / Institut national de la recherche agronomique (INRA), Unité d’écologie animale et de zoologie agricole, Laboratoire d’acarologie, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
- Instituto Agroforestal Mediterraneo, Universidad Politecnica de Valencia, camino de Vera, 14, 46022 Valencia, Spain
| | - F. Ferragut
- Ecole nationale supérieure agronomique / Institut national de la recherche agronomique (INRA), Unité d’écologie animale et de zoologie agricole, Laboratoire d’acarologie, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
- Instituto Agroforestal Mediterraneo, Universidad Politecnica de Valencia, camino de Vera, 14, 46022 Valencia, Spain
| | - B. Cheval
- Ecole nationale supérieure agronomique / Institut national de la recherche agronomique (INRA), Unité d’écologie animale et de zoologie agricole, Laboratoire d’acarologie, 2 Place Pierre Viala, 34060 Montpellier CEDEX 01, France
- Instituto Agroforestal Mediterraneo, Universidad Politecnica de Valencia, camino de Vera, 14, 46022 Valencia, Spain
| |
Collapse
|
20
|
Britten CM, Gouttefangeas C, Kreiter S. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005. Cancer Immunol Immunother 2006; 55:475-80. [PMID: 16193336 PMCID: PMC11029836 DOI: 10.1007/s00262-005-0059-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2005] [Accepted: 07/01/2005] [Indexed: 10/25/2022]
Abstract
Cancer Immunotherapy 2005 was the third international meeting organized by the Association for Immunotherapy of Cancer (AIC). About 200 participants were attracted by the excellent scientific program that consisted of overview lectures from 25 international speakers in the plenary auditorium and four guided poster sessions during both days of the meeting. The first day of the symposium mainly focused on experience with, and new perspectives in, antibody therapy. On the second day of the meeting, organized as a joint conference together with the Combined Research Grant "Mechanisms of Tumor Defense and Therapeutic Intervention" funded by the German Research Council, the participants had the chance to gain deeper insights into the principles of antigen processing and the regulation of immune responses. Further topics that were discussed mainly in the poster sessions and in the special lecture given by M. Nishimura (Chicago, USA), were "cellular therapies" and "vaccination against cancer". The lectures selected for this report aim to provide an overview of the complete scientific program and give an impression of the lively atmosphere that could be felt from the first until the last session of CIMT 2005.
Collapse
Affiliation(s)
- C M Britten
- III. Medical Department, University of Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
| | | | | |
Collapse
|
21
|
Tixier MS, Kreiter S, Cheval B, Auger P. Morphometric variation between populations of Kampimodromus aberrans (Oudemans) (Acari : Phytoseiidae): implications for the taxonomy of the genus. INVERTEBR SYST 2003. [DOI: 10.1071/is02004] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
This study reports variation between populations of the phytoseiid mite Kampimodromus aberrans (Oudemans). The influence of seasons (summer and winter), different host plants, and localities on morphological variation was investigated to determine the reliability of the parameters usually used to distinguish species in the genus Kampimodromus. This study was conducted in southern France. The specimens examined consisted of three summer and three winter populations each collected from Celtis australis L., Quercus pubescens Willdenow (referred as Q. pubescens no. 1 in the text) and Corylus avellanae L., and three additional summer populations collected from each of Q. pubescens (referred as Q. pubescens no. 2 in the text), Vitis vinifera cv. Carignan and Vitis vinifera cv. Cabernet-Sauvignon. Significant differences were observed between the winter and summer populations. Females of summer populations had longer setae than females of winter populations. However, these differences are usually very small. Greatest differences were observed within the population collected in summer on Q. pubescens no. 1 from which two distinct groups of specimens were distinguished. To determine if more than one species of Kampimodromus were present on this plant, measurements of other closely related species were also included in the analysis. It was concluded that all the females studied belong to K. aberrans. However, the setal variations observed raised the following questions. (i) What is the validity of other closely related species whose setal lengths differ only slightly from those of K. aberrans? (ii) Are setal lengths useful characters to distinguish between closely related species in the genus Kampimodromus?
Collapse
|
22
|
Abstract
This study examined young adolescents'intentions to use moralistic violence and their violence exposure, examining male-female differences. Sixth-grade students (n=702) from Georgia middle schools servicing impoverished communities participated. Data were obtained on the students' exposure to violence, family structure and education level, church attendance, gang interest, drug use, and depression status. The dependent variable, intention to use moralistic violence, was measured with an 11-item scale. Linear regression models were run separately for males and females. Males had significantly higher mean intention to use moralistic violence than females (p=0.002). Males reported being exposed to violence more than females, but exposure decreased as attendance to religious services increased. For these 11-12-year-olds, unconventional peer social norms, such as witnessing violence, increased their intention to use violence while involvement in conventional activities, such as church attendance, decreased it. The protective effect was greater for males than females.
Collapse
Affiliation(s)
- S Barkin
- Wake Forest University School of Medicine, Department of Pediatrics, Winston-Salem, NC 27157, USA.
| | | | | |
Collapse
|
23
|
Kreiter S, Winkelmann N, Schneider PM, Schuler M, Fischer T, Ullmann AJ, Huber C, Derigs HG, Kolbe K. Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 2001; 28:157-61. [PMID: 11509933 DOI: 10.1038/sj.bmt.1703107] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2001] [Accepted: 05/12/2001] [Indexed: 12/31/2022]
Abstract
We investigated whether a T cell-reduced allogeneic stem cell transplant (SCT) with minimal conditioning and subsequent donor lymphocyte infusions (DLI) could reduce the incidence and severity of GVHD while retaining stable engraftment. Five patients with hematological malignancies (three MM, one CLL, one Chediak-Higashi syndrome) were conditioned with TBI (200 cGy). One patient additionally received fludarabine (120 mg/m(2)). CsA and mofetyl-mycophenolate (MMF) were administered to prevent GVHD. All patients were grafted with >3 x 10(6)/kg highly purified CD34(+) cells together with 2 x 10(6)/kg CD3(+) cells (three patients) or 1 x 10(5)/kg CD3(+) cells (two patients). Quick hematopoietic recovery and initial mixed donor chimerism was observed. Treatment-related toxicity was minimal in all but one patient who died of treatment-refractory GVHD on day 112. The four other patients only achieved partial donor T cell chimerism. BM and PBMC donor chimerism was lost between day 40 and 209 despite DLI. Three patients are alive with disease and one is in CR. We conclude that T cell-reduced SCT using 200 cGy as the conditioning regimen does not result in stable hematopoietic engraftment. Predominant donor T cell chimerism is not a prerequisite for initial allogeneic hematopoietic proliferation. However for sustained long-term engraftment it is of major importance.
Collapse
Affiliation(s)
- S Kreiter
- III Medizinische Klinik, Mainz, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Craddock C, Bardy P, Kreiter S, Johnston R, Apperley J, Marks D, Huber C, Kolbe K, Goulding R, Lawler M, Goldman J, Hughes T, Derigs G. Short Report: Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen. Br J Haematol 2000; 111:797-800. [PMID: 11122140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Graft-versus-host disease (GVHD) remains a significant complication in patients undergoing allogeneic stem cell transplantation (SCT) using a reduced intensity conditioning regimen. Although T-cell depletion (TCD) reduces the risk of GVHD after a myeloablative conditioning regimen, it is associated with an increased risk of graft failure. We have therefore examined whether TCD compromises engraftment using a fludarabine-based conditioning regimen. Fifteen patients have been transplanted using such a regimen of whom 13 underwent ex vivo TCD. All but one patient demonstrated durable engraftment and no patient receiving a TCD product developed severe GVHD. Thus, TCD may play a role in GvHD prophylaxis using such regimens.
Collapse
Affiliation(s)
- C Craddock
- Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Craddock C, Bardy P, Kreiter S, Johnston R, Apperley J, Marks D, Huber C, Kolbe K, Goulding R, Lawler M, Goldman J, Hughes T, Derigs G. Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen. Br J Haematol 2000. [DOI: 10.1046/j.1365-2141.2000.02454.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
26
|
Kreiter S, Wehler T, Landt O, Huber C, Derigs HG, Hess G. Rapid identification of minor histocompatibility antigen HA-1 subtypes H and R using fluorescence-labeled oligonucleotides. Tissue Antigens 2000; 56:449-52. [PMID: 11144294 DOI: 10.1034/j.1399-0039.2000.560509.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Donor-recipient disparitiy of the minor histocompatibility antigen HA-1 is relevant for the development of graft-versus-host disease after HLA-matched sibling allogeneic bone marrow transplantation in HLA-A*0201-positive individuals. Two different alleles of HA-1 with a single amino acid polymorphism have been identified. Here we describe a time- and cost-efficient method for HA-1 typing of genomic DNA, using site-specific hybridization probes with the LightCycler. This method was compared with standard techniques as sequencing or allele-specific polymerase chain reaction (PCR) and proved to be specific, reliable and reproducible. We conclude that HA-1-subtyping using fluorescent-labeled oligonucleotides represents a attractive method for the screening of samples before allogeneic transplantation in HLA-A*0201-positive individuals.
Collapse
Affiliation(s)
- S Kreiter
- III, Medical Department of Medicine, Hematology, Oncology and Pulmonology, Johannes Gutenberg-University, Mainz, Germany
| | | | | | | | | | | |
Collapse
|
27
|
Durant RH, Altman D, Wolfson M, Barkin S, Kreiter S, Krowchuk D. Exposure to violence and victimization, depression, substance use, and the use of violence by young adolescents. J Pediatr 2000; 137:707-13. [PMID: 11060539 DOI: 10.1067/mpd.2000.109146] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To examine the relationships among exposure to violence; tobacco, alcohol, and other substance use; depression; church attendance; and the use of violence among very young adolescents. METHODS An 86-item confidential questionnaire was administered to 722 sixth grade students (mean age = 11.9+/-0.8 years) attending 4 middle schools serving neighborhoods in and around public housing. RESULTS Boys had a higher mean violence scale score than girls (P < or =.0001), and students living in public housing had higher violence scale scores than other students (P< or =.0001). Self-reported use of violence was significantly associated with exposure to violence (r =.45); age (r =.28); frequency of church attendance (r = -.14); depression (r =.28); the probability of being alive at age 25 (r = -.09); the frequency of use of cigarettes (r =.39), alcohol (r =.37), and multiple substances (r =.38); and interest in a gang (r =.37). When all of these variables were analyzed with multiple linear regression, multiple substance use, exposure to violence, interest in a gang, male gender, cigarette smoking, and depression level accounted for 49.7% of the variation in the use of violence scale. CONCLUSION Recent multiple substance use and lifetime exposure to violence and victimization were the strongest correlates with the frequency that these youth reported using violence and carrying weapons.
Collapse
Affiliation(s)
- R H Durant
- Department of Pediatrics, The Brenner Center for Child and Adolescent Health, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA
| | | | | | | | | | | |
Collapse
|
28
|
Tixier MS, Kreiter S, Auger P. Colonization of vineyards by phytoseiid mites: their dispersal patterns in the plot and their fate. Exp Appl Acarol 2000; 24:191-211. [PMID: 11108386 DOI: 10.1023/a:1006332422638] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The effect of wind and woody margins on the dispersal and population dynamics of phytoseiid mites was studied in a vine plot for a period of two years. Mites were sampled in the plot and in the surrounding vegetation (crops and natural vegetation) in order to determine phytoseiid mite abundance. The surrounding vegetation was considered to be a reservoir of phytoseiids from where the vine plot could be invaded. Directional and non-directional soil and aerial traps were placed in the plot to determine predatory mite exchange between the two areas. Colonization of the plot occurred in two stages: first, mite migration into the plot, followed by their establishment. The two-year study partially clarified the first of these two stages. Kampimodromus aberrans was the main species caught in the aerial traps. Phytoseiid mite dispersal within the vine plot seemed to be affected by both wind (direction, intensity and regularity) and phytoseiid mite density in the woody margin. However, the woody margin had a large effect only over a short distance. Some observations pointed towards an effect of other reservoir areas but it was not possible to characterize these. The population density of the phytoseiid mites in the plot increased from 1996 to 1998, but these increases are much smaller than one would expect on the basis of the number of mites migrating by air in the plot. Moreover, blocks where most mites were trapped were not the blocks where densities of phytoseiid mites on vine leaves were the largest. It therefore seems likely that not all migrants were able to develop. Their settlement pattern was not determined and this could constitute a potential research focus for the future.
Collapse
Affiliation(s)
- M S Tixier
- ENSA.M-INRA, Department of Plant Protection, Montpellier, France.
| | | | | |
Collapse
|
29
|
Abstract
OBJECTIVE To examine the association between carrying a weapon at school and the age of onset of substance use, other indicators of violence, and other health risk behaviors among middle school students. DESIGN In 1995, a modified version of the Centers for Disease Control and Prevention Youth Risk Behavior Survey was administered to 2227 students (49% were female) attending 53 (of 463) randomly selected middle schools in North Carolina. Weapon carrying on school property during school hours was measured with 2 questions assessing carrying a gun and carrying other weapons such as knives or clubs. The Youth Risk Behavior Survey also assessed other indicators of violence, drug use, suicide plans and attempts, and being threatened with a weapon at school. Variables significantly (P< or =.001) associated with gun and other weapon carrying by chi2 tests were analyzed with stepwise logistic regression using the likelihood ratio approach. Odds ratios (ORs) were adjusted for all other variables in the model and 95% confidence intervals (CIs) were computed. RESULTS Our study showed that 3% of students had carried a gun and 14.1% had carried a knife or club to school. Gun carrying was associated with increased age (OR, 1.57 [95% CI, 1.15-2.14]); male sex (OR, 5.62 [95% CI, 2.42-13.03]); minority ethnicity (OR, 3.30 [95% CI, 1.55-5.05]); and earlier age of onset of cigarette (OR, 0.85 [95% CI, 0.74-0.97]), alcohol (OR, 0.81 [95% CI, 0.71-0.94]), marijuana (OR, 0.81 [95% CI, 0.71-0.92]), and cocaine use (OR, 0.73 [95% CI, 0.62-0.86]). Knife or club carrying was associated with age (OR, 1.32 [95% CI, 1.14-1.53]); male sex (OR, 2.39 [95% CI, 1.77-2.32]); and ear-lier age of onset of cigarette (OR, 0.88 [95% CI, 0.84-0.94]), alcohol (OR, 0.81 [95% CI, 0.76-0.86]), and marijuana use (OR, 0.77 [95% CI, 0.72-0.83]). Gun carrying was also associated with frequency of cigarette (OR, 1.34 [95% CI, 1.14-1.57]), alcohol (OR, 4.59 [95% CI, 1.27-16.58]), cocaine (OR, 2.96 [95% CI, 1.29-6.82]), and marijuana use (OR, 3.66 [95% CI, 1.67-8.06]) after adjusting for male sex and minority ethnicity. Carrying a knife or club was associated with carrying a gun (OR, 1.83 [95% CI, 1.31-2.55]); being threatened with a weapon at school (OR, 1.65 [95% CI, 1.10-2.49]); fighting (OR, 4.62 [95% CI, 2.56-8.37]); frequency of alcohol (OR, 2.91 [95% CI, 1.88-4.50]) and cigarette use (OR, 1.20 [95% CI, 1.10-1.31]); and a suicide plan (OR, 1.54 [95% CI, 1.07-2.20]). CONCLUSIONS Middle school students are more likely to carry a knife or club (14.1%) than a gun (3%) to school. Young adolescents who initiate substance use early and engage in it frequently are more likely to carry guns and other weapons to school, after adjusting for age, sex, and ethnicity. Being threatened with a weapon at school and fighting were only associated with knife or club carrying at school. These findings suggest that school-based prevention programs targeting both violence prevention and substance use should be introduced in elementary school.
Collapse
Affiliation(s)
- R H DuRant
- Department of Pediatrics, Brenner Children's Hospital, Wake Forest University School of Medicine, Winston-Salem, NC 25157-1081, USA.
| | | | | | | | | |
Collapse
|
30
|
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML. Bone Marrow Transplant 1998; 21:1029-36. [PMID: 9632277 DOI: 10.1038/sj.bmt.1701229] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
High-dose chemotherapy with autologous transplantation of in vivo purged PBSC is a new and interesting therapeutic option for CML patients not eligible for allogeneic transplantation. We investigated the feasibility and toxicity of this approach in 57 patients with Ph-positive CML. For mobilization of Ph-negative PBSC, patients were treated either with '5 + 2/7 + 3'- type chemotherapy or with 'mini-ICE/ICE' chemotherapy followed by administration of G-CSF. Fourteen patients were in early chronic phase, 30 patients in late chronic phase and 13 patients in accelerated phase (AP) or blast crisis (BC). Cytogenetic responses in the PBSC harvests were dependent on both disease stage and type of chemotherapy: in late chronic phase and AP/BC, a complete or major cytogenetic response could be obtained in nine out of 13 patients treated with 'mini-ICE/ICE' but only in three out of 23 patients treated with '5 + 2/7 + 3' chemotherapy. However, in early chronic phase a Ph-negative autograft could be obtained in three out of eight patients upon mobilization with '5 + 2' chemotherapy. Thirty-one patients underwent PBSC transplantation and all of them successfully engrafted. Post-transplant cytogenetic analysis was available on 21 cases, of whom seven achieved a complete or major cytogenetic response, with two minor cytogenetic remissions. One patient (1/57) in blast crisis died during mobilization therapy (1.8%). Transplantation related mortality was 0%. This study demonstrates that mobilization of Ph-negative PBSC after myelosuppressive chemotherapy is feasible in CML patients and is associated with acceptable toxicity. Autologous transplantation of in vivo purged PBSC is a safe procedure with rapid and complete hematopietic recovery.
Collapse
Affiliation(s)
- T Fischer
- III Medizinische Klinik, Johannes-Gutenberg-Universität, Mainz, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|